dc.contributor.author | Shehab, Abdulla | |
dc.contributor.author | Elnour, Asim | |
dc.contributor.author | Sadik, Adel | |
dc.contributor.author | Abu Mandil, Mahmoud | |
dc.contributor.author | AlShamsi, Ali | |
dc.contributor.author | Al Suwaidi, Aesha | |
dc.contributor.author | Bhagavathula, AkshayaSrikanth | |
dc.contributor.author | Erkekoglu, Pinar | |
dc.contributor.author | Hamad, Farah | |
dc.contributor.author | Al Nuaimi, Saif | |
dc.date.accessioned | 2019-12-16T10:09:44Z | |
dc.date.available | 2019-12-16T10:09:44Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | https://doi.org/10.15537/smj.2015.11.12154 | |
dc.identifier.uri | http://www.smj.org.sa/index.php/smj/article/view/smj.2015.11.12154 | |
dc.identifier.uri | http://hdl.handle.net/11655/19955 | |
dc.relation.isversionof | 10.15537/smj.2015.11.12154 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.title | Clinical Utility Of Dabigatran In United Arab Emirates. A Pharmacovigilance Study | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion | |
dc.relation.journal | Saudi Medical Journal | |
dc.contributor.department | Farmasötik Toksikoloji | |
dc.identifier.volume | 36 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 1290 | |
dc.identifier.endpage | 1298 | |
dc.description.index | PubMed | |
dc.description.index | WoS | |
dc.description.index | Scopus | |